Form 4 Tracker
Esperion Therapeutics, Inc.
ESPR

24 insider filings · Latest: Jul 13, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 17, 2026Jun 18 8:06 PMBenjamin LookerChief Legal Officer
Sale
11,824$3.16$37.3K667,524(D)

View →

Jun 17, 2026Jun 18 8:06 PMSheldon L. KoenigDirector, President and CEO
Sale
53,588$3.16$169.1K2,119,111(D)

View →

Jun 17, 2026Jun 18 8:05 PMBenjamin HalladayChief Financial Officer
Sale
10,773$3.15$34.0K702,829(D)

View →

Jun 17, 2026Jun 17 7:34 PMKoenig Sheldon L.
Proposed Sale
53,588$3.15$169.1K

View →

Jun 17, 2026Jun 17 7:23 PMHalladay Benjamin
Proposed Sale
10,773$3.15$34.0K

View →

Jun 17, 2026Jun 17 7:11 PMLooker Benjamin
Proposed Sale
11,824$3.15$37.3K

View →

Mar 17, 2026Mar 18 8:13 PMBenjamin LookerChief Legal Officer
Sale
5,708$2.70$15.4K679,348(D)

View →

Mar 17, 2026Mar 18 8:13 PMSheldon L. KoenigDirector, President and CEO
Sale
25,578$2.72$69.5K2,172,699(D)

View →

Mar 17, 2026Mar 18 8:12 PMBenjamin HalladayChief Financial Officer
Sale
6,424$2.71$17.4K713,602(D)

View →

Mar 17, 2026Mar 17 7:19 PMHalladay Benjamin
Proposed Sale
6,424$2.70$17.4K

View →

Mar 17, 2026Mar 17 7:17 PMLooker Benjamin
Proposed Sale
5,708$2.70$15.4K

View →

Mar 17, 2026Mar 17 7:12 PMKoenig Sheldon L.
Proposed Sale
25,578$2.72$69.6K

View →

Jan 20, 2026Jan 21 10:17 PMBenjamin LookerGeneral Counsel
Sale
1,689$2.88$4.9K384,216(D)

View →

Jan 20, 2026Jan 20 8:14 PMLooker Benjamin
Proposed Sale
1,689$2.88$4.9K

View →

Dec 17, 2025Dec 17 8:52 PMKoenig Sheldon L.
Proposed Sale
48,244$3.67$177.2K

View →

Dec 17, 2025Dec 17 8:26 PMLooker Benjamin
Proposed Sale
6,517$3.67$23.9K

View →

Dec 17, 2025Dec 17 8:18 PMHalladay Benjamin
Proposed Sale
7,337$3.67$26.9K

View →

Oct 17, 2025Oct 17 7:13 PMLooker Benjamin
Proposed Sale
1,248$2.62$3.3K

View →

Sep 17, 2025Sep 17 7:37 PMKoenig Sheldon L.
Proposed Sale
28,427$2.79$79.2K

View →

Sep 17, 2025Sep 17 7:30 PMHalladay Benjamin
Proposed Sale
7,046$2.81$19.8K

View →

Page 1 of 3

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 13, 2026Jul 13 8:06 PMRobert E. HoffmanDirector
Disposition
47,0400(D)

View →

Jul 13, 2026Jul 13 8:05 PMMartin J CarrollDirector
Disposition
97,5000(D)

View →

Jul 13, 2026Jul 13 8:05 PMJay ShepardDirector
Disposition
97,5000(D)

View →

Jul 13, 2026Jul 13 8:05 PMZ. H. Fischer SethDirector
Disposition
97,5000(D)

View →

Jul 13, 2026Jul 13 8:04 PMJohn Craig ThompsonDirector
Disposition
40,0000(D)

View →

Jul 13, 2026Jul 13 8:04 PMBenjamin LookerChief Legal Officer
Disposition
620,2300(D)

View →

Jul 13, 2026Jul 13 8:03 PMBenjamin HalladayChief Financial Officer
Disposition
634,2700(D)

View →

Jul 13, 2026Jul 13 8:03 PMSheldon L. KoenigDirector, President and CEO
Disposition
2,042,4600(D)

View →

Mar 13, 2026Mar 16 8:20 PMBenjamin LookerChief Legal Officer
Grant/Award
269,230$2.44269,230(D)

View →

Mar 13, 2026Mar 16 8:20 PMSheldon L. KoenigDirector, President and CEO
Grant/Award
647,460$2.44647,460(D)

View →

Mar 13, 2026Mar 16 8:19 PMBenjamin HalladayChief Financial Officer
Grant/Award
221,270$2.44221,270(D)

View →